These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hemostasis and cancer: tumor cells induce the expression of tissue factor-like procoagulant activity on endothelial cells. Maiolo A; Tua A; Grignani G Haematologica; 2002 Jun; 87(6):624-8. PubMed ID: 12031919 [TBL] [Abstract][Full Text] [Related]
5. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants. Gilbert LC; Gordon SG Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176 [TBL] [Abstract][Full Text] [Related]
6. [Comparative effect of leukocytes from healthy persons and patients with chronic lymphadenosis and myelosis on blood coagulation]. Kuznik BI; Kuz'menko EL Probl Gematol Pereliv Krovi; 1971 Jun; 16(6):32-5. PubMed ID: 5119061 [No Abstract] [Full Text] [Related]
7. [Hemostasis and tumor invasion. Therapeutic implications]. Cattan A Bull Cancer; 1984; 71(5):481-93. PubMed ID: 6395923 [TBL] [Abstract][Full Text] [Related]
8. [Antithrombogenic activity of blood vessel walls in the pathogenesis of metastasis in tumor-bearing animals]. Liubina LV; Ziablitskiĭ VM Patol Fiziol Eksp Ter; 1996; (3):32-4. PubMed ID: 8966053 [TBL] [Abstract][Full Text] [Related]
9. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells. Gunji Y; Gorelik E Cancer Res; 1988 Sep; 48(18):5216-21. PubMed ID: 3409246 [TBL] [Abstract][Full Text] [Related]
11. [Development and dissemination of malignant tumors and hemostasis]. Kher A; Hilgard P Pathol Biol (Paris); 1982 Dec; 30(10):861-7. PubMed ID: 6760066 [TBL] [Abstract][Full Text] [Related]
12. [Development and dissemination of malignant tumors, and hemostasis]. Kher A; Hilgard P Sem Hop; 1983 Apr; 59(17):1348-54. PubMed ID: 6306819 [TBL] [Abstract][Full Text] [Related]
13. [State of coagulation hemostasis and fibrinolysis processes in dynamics of rapidly progressing forms of botulinal intoxication]. Chesnokova NP; Kirichuk VF; Sin'keev MV Biull Eksp Biol Med; 1990 Dec; 110(12):637-8. PubMed ID: 2083368 [TBL] [Abstract][Full Text] [Related]
14. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Johansson PI; Bochsen L; Andersen S; Viuff D Transfusion; 2008 Nov; 48(11):2377-83. PubMed ID: 18657078 [TBL] [Abstract][Full Text] [Related]
16. Effect of antihemostatic agents on experimental tumor dissemination. Francis JL; Amirkhosravi A Semin Thromb Hemost; 2002 Feb; 28(1):29-38. PubMed ID: 11885023 [TBL] [Abstract][Full Text] [Related]
17. [Effects of blood coagulating and fibrinolytic activity of tumor on the state of systemic hemostasis in patients with stomach cancer]. Zyrianov BN; Karpov AB; Udut VV; Tsisik RM; Tikhonov VI; Tiutrin II Vopr Onkol; 1990; 36(11):1316-21. PubMed ID: 2281636 [TBL] [Abstract][Full Text] [Related]
18. [Effect of various drugs on platelet aggregation and liberation of platelet factor 4 (anti-heparin factor)]. Farbiszewski R; Niewiarowski S; Poplawski A Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):470-6. PubMed ID: 4193163 [No Abstract] [Full Text] [Related]
19. [Biological effects of thrombin]. Malezhik LP; Al'fonsov VV; Kuznik BI Fiziol Zh SSSR Im I M Sechenova; 1984 Jan; 70(1):16-22. PubMed ID: 6698246 [TBL] [Abstract][Full Text] [Related]
20. Effect of fibrinolysis inhibitor and chemotherapeutics on the growth of human cancers transplanted into nude mice and in tissue culture. Iwakawa A; Tanaka K Invasion Metastasis; 1982; 2(4):232-48. PubMed ID: 7188396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]